Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018

EHA 2018: Initial results of the INSIGHT trial in multiple myeloma

Prof Efstathios Kastritis and Dr Zhengzheng Fu
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma ( Prof Efstathios Kastritis and Dr Zhengzheng Fu )
16 Jun 2018

EHA 2018: The unmet needs in maintenance therapy for multiple myeloma

Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018

EHA 2018: Results of the OPTIMISMM trial

Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
EHA 2018: Results of the OPTIMISMM trial ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
15 Jun 2018

Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma

Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018

Disease control in advanced Hodgkin lymphoma

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Rituximab in combination therapies for FL: Interim results

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

Mapping 3D genome dynamics in B cells

Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018

What does progression-free survival mean for breast cancer patients?

Dr Peter Schmid - Barts Cancer Institute, London, UK
What does progression-free survival mean for breast cancer patients? ( Dr Peter Schmid - Barts Cancer Institute, London, UK )
4 Jun 2018

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer

Dr David Miller - The University of Texas Southwestern Medical Center
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )
2 Jun 2018

First-in-human phase 1 study of TAK-931 for solid tumours

Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )
2 Jun 2018